Achilles Therapeutics Statistics
Total Valuation
ACHL has a market cap or net worth of $38.40 million. The enterprise value is -$69.71 million.
| Market Cap | 38.40M |
| Enterprise Value | -69.71M |
Important Dates
The last earnings date was Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACHL has 41.09 million shares outstanding.
| Shares Outstanding | 41.09M |
| Owned by Insiders (%) | 6.52% |
| Owned by Institutions (%) | 57.27% |
| Float | 21.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.29 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.63, with a Debt / Equity ratio of 0.03.
| Current Ratio | 9.63 |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.00% and return on invested capital (ROIC) is -52.77%.
| Return on Equity (ROE) | -43.00% |
| Return on Assets (ROA) | -37.90% |
| Return on Capital (ROIC) | -52.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$315,848 |
| Employee Count | 204 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ACHL has paid $424,000 in taxes.
| Income Tax | 424,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.29% in the last 52 weeks. The beta is 1.25, so ACHL's price volatility has been higher than the market average.
| Beta (1Y) | 1.25 |
| 52-Week Price Change | -3.29% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 58.70 |
| Average Volume (30 Days) | 589,538 |
Short Selling Information
| Short Interest | 24,042 |
| Short Previous Month | 37,826 |
| Short % of Shares Out | 0.09% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.07 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -71.00M |
| Pretax Income | -64.01M |
| Net Income | -64.43M |
| EBITDA | -59.22M |
| EBIT | -64.01M |
| Earnings Per Share (EPS) | -$1.60 |
Balance Sheet
The company has $112.32 million in cash and $4.21 million in debt, giving a net cash position of $108.11 million or $2.63 per share.
| Cash & Cash Equivalents | 112.32M |
| Total Debt | 4.21M |
| Net Cash | 108.11M |
| Net Cash Per Share | $2.63 |
| Equity / Book Value | 130.35M |
| Book Value Per Share | 3.17 |
| Working Capital | 117.77M |
Cash Flow
In the last 12 months, operating cash flow was -$48.10 million and capital expenditures -$1.34 million, giving a free cash flow of -$49.44 million.
| Operating Cash Flow | -48.10M |
| Capital Expenditures | -1.34M |
| Free Cash Flow | -49.44M |
| FCF Per Share | -$1.23 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACHL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.38% |
| Shareholder Yield | -1.38% |
| Earnings Yield | -167.79% |
| FCF Yield | -128.75% |
Analyst Forecast
The average price target for ACHL is $2.83, which is 198.59% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.83 |
| Price Target Difference | 198.59% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 17.06% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |